The CRASH trial protocol (Corticosteroid randomisation after significant head injury) [ISRCTN74459797].

Authors:
The CRASH trial management group; The CRASH trial collaborators .

Journal:
BMC Emerg Med

Publication Year: 2001

DOI:
10.1186/1471-227X-1-1

PMCID:
PMC33506

PMID:
11439175

View on PubMed View on PMC View Publisher

Journal Information

Journal Title: BMC Emerg Med

Detailed journal information not available.

Publication Details

Subject Category: Emergency Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score

1/6

0.0% Transparent

Transparency Indicators

Click on green indicators to view evidence text

Core Indicators

Data Sharing

Code Sharing

COI Disclosure

Funding Disclosure

Evidence found in paper:

"Financial support Medical Research Council funding covers meetings and central organisational costs only. Pharmacia Corporation are donating drug and placebo, but the design, management and finance of the study are entirely independent of them. Methylprednisolone is not a new product. Really large trials of such drugs, involving many hospitals, are important for future patients but are practicable only if those collaborating in them do so without payment (except for recompense of any minor local costs that may arise)."

Protocol Registration

Open Access

Additional Indicators

Replication

Novelty Statement

Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025